Scatena R

From Bioblast
Revision as of 15:36, 11 December 2018 by Plangger Mario (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


e-COST MitoEAGLE
e-COST MitoEAGLE countries
MitoGlobal
MitoEAGLE
News and Events         About COST Action MitoEAGLE         Working Groups         MiP/MitoEAGLE Conference, WG and MC Meeting 2019 Belgrade RS         MitoEAGLE Preprint States and rates         Short-Term Scientific Missions         Inclusiveness Target Countries         Management Committee         Members    


MiPsociety
COST Action CA15203 MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping


 

Scatena R


MitoPedia topics: EAGLE 

COST: Member COST WG1: WG1 COST WG2: WG2 COST WG3: WG3 COST WG4: WG4 COST Mentor: Mentor

MC Member - Management Committee MitoEAGLE
Name Scatena Roberto, Prof. PhD
Institution
Roberto Scatena
Department of Diagnostics and Laboratory Medicine,

Institute of Biochemistry and Clinical Biochemistry,

Polyclinic A. Gemelli - Catholic University, IT

Address Largo A. Gemelli 8, 00168
City Rome
State/Province
Country Italy
Email roberto.scatena@unicatt.it
Weblink
O2k-Network Lab IT Rome Scatena R



New Open Access Journal

Dr. R. Scatena is the editor of 'Cancer Stem Cells'.


Labels: Field of research: Basic 



Publications

 PublishedReference
Gnaiger 2019 MitoFit Preprint Arch2019Gnaiger E, Aasander Frostner E, Abdul Karim N, Abdel-Rahman EA, Abumrad NA, Acuna-Castroviejo D, Adiele RC, et al (2019) Mitochondrial respiratory states and rates. MitoFit Preprint Arch doi:10.26124/mitofit:190001.v6.
Bottoni 2019 Adv Exp Med Biol2019Bottoni P, Scatena R (2019) Mitochondrial metabolism in cancer. A tangled topic. Which role for proteomics? Adv Exp Med Biol 1158:1-16.
Scatena 2019 Curr Med Chem2019Scatena R, Bottoni P (2019) The tangled mitochondrial metabolism in cancer: An innovative pharmacological approach. Curr Med Chem [Epub ahead of print].
Tesori 2015 Sci Rep2015Tesori V, Piscaglia AC, Samengo D, Barba M, Bernardini C, Scatena R, Pontoglio A, Castellini L, Spelbrink JN, Maulucci G, Puglisi MA, Pani G, Gasbarrini A (2015) The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing. Sci Rep 5:9149.
Scatena 2012 Adv Exp Med Biol2012Scatena R, Bottoni P, Giardina B (eds) (2012) Advances in mitochondrial medicine. Adv Exp Med Biol 942:p461.

Abstracts

 PublishedReference
Scatena 2018 MiP20182018
Scatena Roberto
No abstract.
Scatena 2017 MITOEAGLE Obergurgl2017
Roberto Scatena
Cancer stem cell differentiation induced by PPAR ligands. Which role for an inhibition of mitochondrial respiratory chain?
Scatena 2017 Abstract MITOEAGLE Barcelona2017
COST Action MITOEAGLE
Mitochondria and cancer stem cells in hepatocarcinoma. An illustrative example of a tangled methodological approach.


MitoEAGLE Feedback

Specifically, we are studying mitochondrial metabolism in cancer cells. At this aim we are also participating to mt-HPP project, an Italian consortium whose target is a definition of mitochondrial proteome in health and disease. Briefly, my specific activity is to compare mitochondrial functional status with the mitochondrial proteome picture in different human cell line. I do think that a "contact" between these two important initiatives should be useful for both.
Moreover, to stress the potential translational applications of research on bioenergetics in general and on mitochondria in particular (as also recently highlighted by Paolo Bernardi during EBEC 2016), I would like to suggest to begin to think to a careful pathophysiological classification of all mitochondriopathies (inborn and acquired, primary and secondary, ECR of metabolic related and so on) to reinforce the concept of a “mitochondrial medicine”, concept, until now, too often neglected with dramatic consequences. - Scatena Roberto (2016).


Participated at